Myeloid takl acts as a negative regulator of the LPS response and mediates resistance to endotoxemia

21Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

TGFβ-activated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, is considered a key intermediate in a multitude of innate immune signaling pathways. Yet, the specific role of TAK1 in the myeloid compartment during inflammatory challenges has not been revealed. To address this question, we generated myeloid-specific kinase-dead TAK1 mutant mice. TAK1 deficiency in macrophages results in impaired NF-κB and JNK activation upon stimulation with lipopolysaccharide (LPS). Moreover, TAK1-deficient macrophages and neutrophils show an enhanced inflammatory cytokine profile in response to LPS stimulation. Myeloid-specific TAK1 deficiency in mice leads to increased levels of circulating IL-1β, TNF and reduced IL-10 after LPS challenge and sensitizes them to LPS-induced endotoxemia. These results highlight an antiinflammatory role for myeloid TAK1, which is essential for balanced innate immune responses and host survival during endotoxemia. © 2012 Eftychi et al.

Cite

CITATION STYLE

APA

Eftychi, C., Karagianni, N., Alexiou, M., Apostolaki, M., & Kollias, G. (2012). Myeloid takl acts as a negative regulator of the LPS response and mediates resistance to endotoxemia. PLoS ONE, 7(2). https://doi.org/10.1371/journal.pone.0031550

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free